CAMPOS, FABIO E. dePERINI, EFRAIN A.ZAPPAROLI JUNIOR, CARLOS L.CALVO, WILSON A.P.STAROVOITOVA, VALERIIA N.2018-11-292018-11-292018CAMPOS, FABIO E. de; PERINI, EFRAIN A.; ZAPPAROLI JUNIOR, CARLOS L.; CALVO, WILSON A.P.; STAROVOITOVA, VALERIIA N. Main steps for radiopharmaceuticals hot cells validation in accordance with GMP requirements: methodology and practical guide. <b>Journal of Environmental Science and Engineering A</b>, v. 7, p. 132-139, 2018. DOI: <a href="https://dx.doi.org/10.17265/2162-5298/2018.03.004">10.17265/2162-5298/2018.03.004</a>. Disponível em: http://repositorio.ipen.br/handle/123456789/29285.1934-8932http://repositorio.ipen.br/handle/123456789/29285The worldwide GMP (Good Manufacturing Practices) guidelines issued for injectable pharmaceuticals globally agree that the vials filling operation must be performed under air cleanliness Grade A. The air cleanliness classifications adopted by the WHO (World Health Organization) define the particle diameter size, the sampling occupancy state and the limit concentration of viable particles. To reach conformity regarding the microbial limits foreseen at the GMP guidelines, a microbiological monitoring program must be stablished for selected sampling points such as active air sampling, passive air sampling (settle plate method), surfaces sampling (contact method), personnel sampling (gloves and clothes), compressed gas, materials and equipment that may interfere and compromise the product microbiological quality. The key elements for a GMP certification are directly related to a qualification and validation program for radiopharmaceutical manufacturers that must be clearly defined and documented by a validation master plan, foreseen by the manufactures Quality Assurance office. This study describes each qualification step and test for DQ (Design Qualification), IQ (Installation Qualification), OQ (Operation Qualification) and PQ (Performance Qualification) that must be carried out and carefully planned when it comes to hot cells and isolator systems in accordance with the GMP requirements foreseen by international regulatory and supervisory bodies.132-139openAccessradiopharmaceuticalsproductionquality assuranceregulationsstandardsmonitoringquality controlinspectionArtigo de periódico710.17265/2162-5298/2018.03.004aguardandohttps://orcid.org/0000-0002-4316-8335Sem PercentilSem Percentil CiteScore